Of all clinicopathological features considered for this cohort, we found that the high expression of POLR1B was significantly associated with the CRC tumor size (P = 0.002), indicating high expression of POLR1B was related to malignant progression in CRC patients, shown in Supplementary Table 12. Here, POLR1B is linked to colorectal carcinoma.